• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在心脏瓣膜形成过程中,DSCR1基因的表达依赖于NFATc1,并且在16三体小鼠中与异常器官发育共定位。

DSCR1 gene expression is dependent on NFATc1 during cardiac valve formation and colocalizes with anomalous organ development in trisomy 16 mice.

作者信息

Lange Alexander W, Molkentin Jeffery D, Yutzey Katherine E

机构信息

Division of Molecular Cardiovascular Biology, Children's Medical Center Cincinnati ML 7020, Cincinnati, OH 45229, USA.

出版信息

Dev Biol. 2004 Feb 15;266(2):346-60. doi: 10.1016/j.ydbio.2003.10.036.

DOI:10.1016/j.ydbio.2003.10.036
PMID:14738882
Abstract

The Down syndrome critical region 1 (DSCR1) gene is present in the region of human chromosome 21 and the syntenic region of mouse chromosome 16, trisomy of which is associated with congenital heart defects observed in Down syndrome. DSCR1 encodes a regulatory protein in the calcineurin/NFAT signal transduction pathway. During valvuloseptal development in the heart, DSCR1 is expressed in the endocardium of the developing atrioventricular and semilunar valves, the muscular interventricular septum, and the ventricular myocardium. Human DSCR1 contains an NFAT-rich calcineurin-responsive element adjacent to exon 4. Transgenic mice generated with a homologous regulatory region of the mouse DSCR1 gene linked to lacZ (DSCR1(e4)/lacZ) show gene activation in the endocardium of the developing valves and aorticopulmonary septum of the heart, recapitulating a specific subdomain of endogenous DSCR1 cardiac expression. DSCR1(e4)/lacZ expression in the developing valve endocardium colocalizes with NFATc1 and, endocardial DSCR1(e4)/lacZ, is notably reduced or absent in NFATc1(-/-) embryos. Furthermore, expression of the endogenous DSCR1(e4) isoform is decreased in the outflow tract of NFATc1(-/-) hearts, and the DSCR1(e4) intragenic element is trans-activated by NFATc1 in cell culture. In trisomy 16 (Ts16) mice, expression of endogenous DSCR1 and DSCR1(e4)/lacZ colocalizes with anomalous valvuloseptal development, and transgenic Ts16 hearts have increased beta-galactosidase activity. DSCR1 and DSCR1(e4)/lacZ also are expressed in other organ systems affected by trisomy 16 in mice or trisomy 21 in humans including the brain, eye, ear, face, and limbs. Together, these results show that DSCR1(e4) expression in the developing valve endocardium is dependent on NFATc1 and support a role for DSCR1 in normal cardiac valvuloseptal formation as well as the abnormal development of several organ systems affected in individuals with Down syndrome.

摘要

唐氏综合征关键区域1(DSCR1)基因位于人类21号染色体区域以及小鼠16号染色体的同区域,该区域的三体性与唐氏综合征中观察到的先天性心脏缺陷相关。DSCR1在钙调神经磷酸酶/NFAT信号转导通路中编码一种调节蛋白。在心脏瓣膜间隔发育过程中,DSCR1在发育中的房室瓣和半月瓣的心内膜、肌性室间隔以及心室心肌中表达。人类DSCR1在第4外显子附近含有一个富含NFAT的钙调神经磷酸酶反应元件。用与lacZ相连的小鼠DSCR1基因的同源调控区域产生的转基因小鼠(DSCR1(e4)/lacZ)显示,在发育中的心脏瓣膜和主动脉肺动脉间隔的心内膜中有基因激活,重现了内源性DSCR1心脏表达的一个特定亚域。发育中的瓣膜心内膜中DSCR1(e4)/lacZ的表达与NFATc1共定位,并且在NFATc1(-/-)胚胎中,心内膜DSCR1(e4)/lacZ明显减少或缺失。此外,内源性DSCR1(e4)异构体在NFATc1(-/-)心脏的流出道中表达降低,并且DSCR1(e4)基因内元件在细胞培养中被NFATc1反式激活。在16三体(Ts16)小鼠中,内源性DSCR1和DSCR1(e4)/lacZ的表达与异常的瓣膜间隔发育共定位,并且转基因Ts16心脏具有增加的β-半乳糖苷酶活性。DSCR1和DSCR1(e4)/lacZ也在受小鼠16三体或人类21三体影响的其他器官系统中表达,包括脑、眼、耳、面部和四肢。总之,这些结果表明发育中的瓣膜心内膜中DSCR1(e4)的表达依赖于NFATc1,并支持DSCR1在正常心脏瓣膜间隔形成以及唐氏综合征患者中受影响的几个器官系统的异常发育中发挥作用。

相似文献

1
DSCR1 gene expression is dependent on NFATc1 during cardiac valve formation and colocalizes with anomalous organ development in trisomy 16 mice.在心脏瓣膜形成过程中,DSCR1基因的表达依赖于NFATc1,并且在16三体小鼠中与异常器官发育共定位。
Dev Biol. 2004 Feb 15;266(2):346-60. doi: 10.1016/j.ydbio.2003.10.036.
2
Restoration of DSCR1 to disomy in the trisomy 16 mouse model of Down syndrome does not correct cardiac or craniofacial development anomalies.在唐氏综合征的16三体小鼠模型中,将DSCR1恢复为二倍体并不能纠正心脏或颅面发育异常。
Dev Dyn. 2005 Jul;233(3):954-63. doi: 10.1002/dvdy.20433.
3
Down syndrome critical region-1 is a transcriptional target of nuclear factor of activated T cells-c1 within the endocardium during heart development.唐氏综合征关键区域-1是心脏发育过程中心内膜内活化T细胞核因子-c1的转录靶点。
J Biol Chem. 2007 Oct 19;282(42):30673-9. doi: 10.1074/jbc.M703622200. Epub 2007 Aug 10.
4
Characterization of Nfatc1 regulation identifies an enhancer required for gene expression that is specific to pro-valve endocardial cells in the developing heart.Nfatc1调控的特征鉴定出一个基因表达所需的增强子,该增强子对发育中心脏的前瓣膜心内膜细胞具有特异性。
Development. 2005 Mar;132(5):1137-46. doi: 10.1242/dev.01640. Epub 2005 Feb 2.
5
A field of myocardial-endocardial NFAT signaling underlies heart valve morphogenesis.心肌-心内膜核因子活化T细胞信号传导领域是心脏瓣膜形态发生的基础。
Cell. 2004 Sep 3;118(5):649-63. doi: 10.1016/j.cell.2004.08.010.
6
NFATc1 expression in the developing heart valves is responsive to the RANKL pathway and is required for endocardial expression of cathepsin K.发育中心脏瓣膜中的NFATc1表达对RANKL通路有反应,并且是组织蛋白酶K在心内膜表达所必需的。
Dev Biol. 2006 Apr 15;292(2):407-17. doi: 10.1016/j.ydbio.2006.01.017.
7
Sculpting heart valves with NFATc and VEGF.利用NFATc和VEGF塑造心脏瓣膜。
Cell. 2004 Sep 3;118(5):532-4. doi: 10.1016/j.cell.2004.08.022.
8
DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways.DSCR1在唐氏综合征中过度表达,是钙调神经磷酸酶介导的信号通路的抑制剂。
Hum Mol Genet. 2000 Jul 1;9(11):1681-90. doi: 10.1093/hmg/9.11.1681.
9
NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21.21号染色体上DSCR1和DYRK1A剂量增加导致的NFAT失调。
Nature. 2006 Jun 1;441(7093):595-600. doi: 10.1038/nature04678. Epub 2006 Mar 22.
10
Trisomy of the Dscr1 gene suppresses early progression of pancreatic intraepithelial neoplasia driven by oncogenic Kras.Dscr1 基因三体抑制致癌 Kras 驱动的胰腺上皮内瘤变的早期进展。
Biochem Biophys Res Commun. 2013 Oct 11;440(1):50-5. doi: 10.1016/j.bbrc.2013.09.033. Epub 2013 Sep 13.

引用本文的文献

1
Calcineurin inhibition may prevent Alzheimer disease in people with Down syndrome.抑制钙调神经磷酸酶可能预防唐氏综合征患者患阿尔茨海默病。
Alzheimers Dement. 2025 Mar;21(3):e70034. doi: 10.1002/alz.70034.
2
Genetics and Molecular Basis of Congenital Heart Defects in Down Syndrome: Role of Extracellular Matrix Regulation.唐氏综合征先天性心脏病的遗传学和分子基础:细胞外基质调节的作用。
Int J Mol Sci. 2023 Feb 2;24(3):2918. doi: 10.3390/ijms24032918.
3
New Molecular and Organelle Alterations Linked to Down Syndrome Heart Disease.与唐氏综合征心脏病相关的新分子和细胞器改变
Front Genet. 2022 Jan 18;12:792231. doi: 10.3389/fgene.2021.792231. eCollection 2021.
4
Cardiovascular physiology and pathophysiology in Down syndrome.唐氏综合征的心血管生理学和病理生理学。
Physiol Res. 2022 Mar 25;71(1):1-16. doi: 10.33549/physiolres.934791. Epub 2022 Jan 19.
5
Molecular link between circadian clocks and cardiac function: a network of core clock, slave clock, and effectors.昼夜节律钟与心脏功能的分子联系:核心钟、从属钟和效应器网络。
Curr Opin Pharmacol. 2021 Apr;57:28-40. doi: 10.1016/j.coph.2020.10.006. Epub 2020 Nov 12.
6
Molecular mechanisms of congenital heart disease in down syndrome.唐氏综合征先天性心脏病的分子机制
Genes Dis. 2019 Jul 8;6(4):372-377. doi: 10.1016/j.gendis.2019.06.007. eCollection 2019 Dec.
7
RCAN1 Knockdown Reverts Defects in the Number of Calcium-Induced Exocytotic Events in a Cellular Model of Down Syndrome.在唐氏综合征细胞模型中,敲低RCAN1可逆转钙诱导的胞吐事件数量的缺陷。
Front Cell Neurosci. 2018 Jul 6;12:189. doi: 10.3389/fncel.2018.00189. eCollection 2018.
8
Endothelial loss of Fzd5 stimulates PKC/Ets1-mediated transcription of Angpt2 and Flt1.Fzd5 内皮细胞丢失刺激 Angpt2 和 Flt1 的 PKC/Ets1 介导的转录。
Angiogenesis. 2018 Nov;21(4):805-821. doi: 10.1007/s10456-018-9625-6. Epub 2018 May 29.
9
Decreased activity of RCAN1.4 is a potential risk factor for congenital heart disease in a Han Chinese population.RCAN1.4活性降低是汉族人群先天性心脏病的一个潜在危险因素。
Protein Cell. 2018 Dec;9(12):1039-1044. doi: 10.1007/s13238-018-0525-8.
10
What people with Down Syndrome can teach us about cardiopulmonary disease.唐氏综合征患者能让我们了解到的关于心肺疾病的知识。
Eur Respir Rev. 2017 Feb 21;26(143). doi: 10.1183/16000617.0098-2016. Print 2017 Jan.